Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3M, Avectas, Bioiq, Biotelemetry Inc., Bluewave Technologies, Bruker, Bruker-Hain Diagnostics, Foldax, Fujifilm, Kyocera, Lumendi, Medtronic, Novacyt SA, Oblation Therapeutics, Omnipathology, PRA Health Sciences, Precision Nanosystems, Predictive Technology, Primer Design, Showa Optronics, Spok, Stemcell Technologies, T2 Biosystems, Twist Bioscience, Vycellix.

Med-tech firms raising money in public or private financings, including: Royal Philips, Thermogenesis Holdings, Titan Medical.

New hires and promotions in the med-tech industry, including: Biovica, Ohana Biosciences, Specialty Renal Products.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Daiichi, EMD, Exelixis, Gilead, Infinity, Intrabio, Sumitomo, Takeda, Valneva.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aytu, Beigene, Biogen, Biosig, BMS, Brightinsight, Cannabics, Cansino, Celgene, Cold Genesys, Debiopharm, F. Hoffmann-La Roche, Forge, Immuron, Laekna, Lidds, Mateon, Novartis, PCI. 3B, Redhill, Repertoire, Sorrento, Stemcell, Turn, Vir, Wuxi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allakos, Avadel, Cassava, Diffusion, Eloxx, Immutep, Lundbeck, Mind Medicine, Onconova, Opko.

Biopharmas raising money in public or private financings, including: Eyenovia, Kallyope, Vistagen.

New hires and promotions in the biopharma industry, including: Immuneering, Ohana, Sosei.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Anheart, Applied DNA Sciences, Astrazeneca, Bellerophon, Can-Fite, Cansino Biologics, Cytodyn, Genentech, Hansoh, Merck, Novartis, Synairgen, Takis.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Cytodyn, Genentech, Humanigen, Immutep, Inxmed (Shanghai) Co., Recce.